• 셀메드
• /
• 제14권1호
• /
• pp.64.1-64.5
• /
• 2024

Objective: A case study on improvement of Meniere's Disease through Ortho-Cellular Nutrition Therapy (OCNT). Methods: A Korean female in her 40s was incapable of daily living activities due to severe Ménière's Disease symptoms. OCNT was applied and the degree of symptoms was tracked. Results: Symptoms of Ménière's disease including headache and dizziness were improved after administering OCNT over approximately 4 months. Conclusion: Administering OCNT may help alleviate symptoms of patients suffering difficulty in daily life due to Ménière's Disease.

• Clinical and Experimental Pediatrics
• /
• 제52권5호
• /
• pp.557-566
• /
• 2009

목 적 : 소아에서 나타나는 편두통은 어른과는 달리 구토, 복통, 어지럼증 등의 관련 증상이 두통 자체보다도 더 뚜렷하다는 특징이 있다. 주기성구토증후군(cyclic vomiting syndrome, CVS), 복부편두통(abdominal migraine, AM), 소아기 양성 돌발현훈(benign paroxysmal vertigo of childhood, BPVC)은 최근 새롭게 개편된 제2차 국제두통학회 두통분류에서 편두통의 전 단계 질환으로 나타나는 소아기주기성증후군으로 분류되었으나 현재까지 국내에서는 이 질환에 대한 보고는 아직 없는 상태이다. 이에 우리나라 실제 임상현장에서 관찰되는 소아기주기성증후군을 구성하는 세 가지 질환에 대하여 각각의 빈도와 그 임상 양상을 알아보고 외국의 연구들과 비교 분석하여 어떤 차이를 보이는지 살펴봄으로써 우리나라 소아청소년에서의 이 질환의 특징을 확인하기 위하여 본 연구를 실시하였다. 방 법 : 2006년 1월부터 2007년 12월까지 대한민국 도심에 위치한 주요 5개 병원의 소아신경과를 방문한 환자를 대상으로 실시한 연구로서 2차 개정된 국제두통학회의 두통분류 진단기준에 따라 갑작스런 구토, 복통, 어지럼증을 보이는 환자를 각각 CVS, AM, BPVC 세 개의 군으로 분류하여 그들 사이의 특성을 비교 분석하였다. 결 과 : 1) 대상 환자는 총 44명으로 CVS 20명, AM 8명, BPVC 16명이었고 남아 16명, 여아 28명으로 1:1.75의 남녀 비율을 보였으며(CVS 1:3, AM 1:1.7, BPVC 1:1), 외국의 보고와는 달리 본 연구에서는 여아가 많았다. 2) 증상이 시작된 연령은 CVS $6.3{\pm}3.6$세, AM $8.5{\pm}2.7$세, BPVC $8.5{\pm}2.9$세 이었으며 진단이 이루어진 연령은 각각 $8.0{\pm}3.4$세, $10.5{\pm}2.6$세, $10.1{\pm}3.2$세로 세 질환 모두 증상의 시작 연령 및 진단 연령이 외국에 비해 늦었다. 3) 대상환자 중 17명(38.6%)에서 반복성 두통 증상이 동반 되였으며[CVS 7명(35%), AM 4명(50%), BPVC 6명(37.5%)], 세 질환 중 AM에서 가장 많이 동반되었다. 4) 전형적인 편두통 증상은 11명(25%)에서 동반되었으며 세 질환 모두에서 비슷한 비율[CVS 5명(25%), AM 2명(25%), BPVC 4명(25%)]으로 나타났다. 5) 편두통의 가족력은 [CVS 4명, (20%), AM 2명(25%), BPVC 3명(18.8%)] 등 총 9명(20.4%)에서 확인할 수 있었으며 통계적으로 의미 있는 차이는 없었으나 AM에서 편두통의 가족력 동반이 가장 많았고, 이는. BPVC에서 가장 많은 편두통 가족력을 보이는 외국의 결과와는 다소 차이가 있었다. 결 론 : 우리나라의 경우 증상의 발현시기 및 진단시기가 모두 외국에 비해 다소 늦은데, 이는 우리나라에서 소아청소년을 치료하는 의료진들이 아직 이 질환을 잘 인지하지 못하고 있기 때문이 아닌지 추론해 볼 수 있다. 원인이 불분명한 반복적인 심한 구토, 복통, 어지럼증을 호소하는 소아에서는 반드시 소아기주기성증후군의 가능성을 의심해 보아야 하며 이것이 이 질환을 성공적으로 치료하게 되는 첫 단계가 될 것으로 사료된다. 향후 더 많은 기관이 참여하는 대규모 역학 조사와 종속연구(longitudinal study)를 통하여 이 질환의 빈도와 자연경과 등을 지속적으로 확인해 나가야겠다.

• 한국의사학회지
• /
• 제24권1호
• /
• pp.43-56
• /
• 2011

Everyone once in a life experience headaches as symptoms are very common. According to a study in a country of more than a week and as many as those who have experienced a headache amounts to 69.4%. In addition, the high reported prevalence of migraine in 30s for 80% of all migraine sufferers daily life interfere with work or was affected. In Western medicine, the cause of headaches is traction or deformation of pain induced tissue like scalp, subcutaneous tissue, muscle, fascia, extracranial arteriovenous, nerves, periosteum. But it turns out there are not cause why pain induced tissue is being tracted or deformated. Therefore, most of the western-therapy is mainly conducted with regimen for a temporary symptom reduction. Therefore, I examined how it has been developed in Chinese Ming Dynasty, the perception of headache, change in disease stage and an etiological cause. Oriental medicine in the treatment of headache is a more fundamental way to have an excellent treatment. The recognition of head in "素問($s{\grave{u}}$ $w{\grave{e}}n$)" and "靈樞($l{\acute{i}}ng$ $sh{\bar{u}}$)" began to appear in 'Soul-神($sh{\acute{e}}n$) dwelling place' and 'where to gather all the Yang-'諸陽之會($zh{\bar{u}}$ $y{\acute{a}}ng$ $zh{\bar{i}}$ $hu{\grave{i}}$)'. Also, head was recognized as '六腑($li{\grave{u}}f{\check{u}}$) 淸陽之氣($q{\bar{i}}ng$ $y{\acute{a}}ng$ $zh{\bar{i}}$ $q{\grave{i}}$) and 五臟($w{\check{u}}$ $z{\grave{a}}ng$) 精血($j{\bar{i}}ng$ $xu{\grave{e}}$) gathering place'. More specific structures such as the brain is considered a sea of marrow(髓海-$su{\check{i}}$ $h{\check{a}}i$) in "內經($n{\grave{e}}i$ $j{\bar{i}}ng$)" and came to recognized place where a stroke occurs. Accompanying development of the recognition about head, there had been changed about the perception of headache and the recognition of the cause and mechanism of headache. And the recognition of headache began to be completed in Ming Dynasty through Jin, Yuan Dynasty. Chinese Ming Dynasty, specially 樓英($l{\acute{o}}u$ $y{\bar{i}}ng$), in "醫學綱目($y{\bar{i}}xu{\acute{e}}$ $g{\bar{a}}ngm{\grave{u}}$)", first enumerated prescription in detail by separating postpartum headache. and proposed treatment of headache especially due to postpartum sepsis(敗血-$b{\grave{a}}i$ $xu{\grave{e}}$). 許浚($x{\check{u}}$ $j{\grave{u}}n$) accepted a variety of views without impartial opinion in explaining one kind of headache in "東醫寶鑑($d{\bar{o}}ng-y{\bar{i}}$ $b{\check{a}}oji{\grave{a}}n)$" 張景岳($zh{\bar{a}}ng$ $j{\check{i}}ng$ $yu{\grave{e}}$), in "景岳全書($j{\check{i}}ng$ $yu{\grave{e}}$ $qu{\acute{a}}nsh{\bar{u}}$)", established his own unique classification system-新舊表裏($x{\bar{i}}nji{\grave{u}}$ $bi{\check{a}}ol{\check{i}}$)-, and offered a clear way even in treatment. Acupuncture treatment of headache in the choice of meridian has been developed as a single acupuncture point. Using the classification of headache to come for future generation as a way of locating acupoints were developed. Chinese Ming Dynasty, there are special treatments like 導引按蹻法($d{\check{a}}o$ y ${\check{i}}n$ ${\grave{a}}n$ $ji{\check{a}}o$ $f{\check{a}}$), 搐鼻法($ch{\grave{u}}$ $b{\acute{i}}$ $f{\check{a}})$, 吐法($t{\check{u}}$ $f{\check{a}}$), 外貼法($w{\grave{a}}i$ $ti{\bar{e}}$ $f{\check{a}}$), 熨法($y{\grave{u}}n$ $f{\check{a}}$), 點眼法($di{\check{a}}n$ $y{\check{a}}n$ $f{\check{a}}$), 熏蒸法($x{\bar{u}}nzh{\bar{e}}ng$ $f{\check{a}}$), 香氣療法($xi{\bar{a}}ngq{\grave{i}}$ $li{\acute{a}}of{\check{a}}$). Most of this therapy in the treatment of headache, it is not used here, but if you use a good fit for today's environment can make a difference.

• 대한소아신경학회지
• /
• 제26권4호
• /
• pp.288-291
• /
• 2018

편마비편두통은 조짐편두통의 드문 아형으로 완전히 회복 가능한 운동 조짐이 동반되며, 가족편마비편두통과 산발편마비편두통으로 나뉘고, 현재까지 가족편마비편두통과 관련된 3가지의 유전자들이 알려져 있다. 전형적인 편마비편두통은 유년기 혹은 청소년기에 시작되며, 20-30분에 걸쳐 점차 진행하는 조짐 증상들이 연속적으로 두통과 동반되어 나타난다. 조짐은 시각, 감각, 운동, 실어성 조짐 등이 흔하고, 종종 기저형편두통의 증상으로도 발생한다. 위약감은 감각 조짐이 나타나는 곳과 관계가 있으며, 감각-운동 조짐은 대개 한쪽 손에서 시작하여 점차 팔과 얼굴 쪽으로 퍼져 간다. 언어 장애는 주로 표현의 장애로 나타나지만, 드물게는 이해의 장애가 동반되기도 한다. 본 증례는 동측 상지의 조짐은 없었고 우측 안면부터 동측 하지로 감각-운동 증상이 진행되었는데 저자가 아는 한 이와 같은 경과를 보인 편마비편두통에 대한 증례 보고는 없었다. 증상 발현 초기 벨 마비로 오인할 수 있는 경과를 보였기에, 편측안면마비를 호소하는 경우 벨 마비 외에 드문 원인으로 뇌졸중 및 편마비편두통 등도 고려해 볼 필요가 있겠다.

• Korean Journal of Acupuncture
• /
• 제40권3호
• /
• pp.62-78
• /
• 2023

Objectives : This study aims to assess the impact of acupotomy on migraine through an examination of clinical studies conducted since 2015. Methods : We conducted a comprehensive search for randomized controlled trials (RCTs) and non-randomized controlled trials (nRCTs) related to acupotomy treatment for migraine, utilizing five Korean online databases (OASIS, Science ON, DBPIA, KISS, RISS), as well as four foreign online databases (CNKI, PubMed, EMBASE, Cochrane Library). We identified a total of 10 relevant studies for analysis. Participants characteristics, treatment points, combination treatments, treatment cycles or frequencies, evaluation indices, efficacy, and adverse events were analyzed. The risk of bias in the 10 RCTs was assessed using the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2.0). Results : A total of 931 participants were included in 10 studies. In the intervention group, the average duration of migraine morbidity ranged from 15.5±4.5 months to 15.9±4.2 years. Six studies based their diagnoses on the International Classification of Headache Disorders (ICHD), while five studies relied on Chinese diagnostic criteria. All studies specified the treatment area as the region exhibiting tenderness or induration on the head and neck. Treatment cycles ranged from a minimum of 2 days to a maximum of 1 week, with the number of days per treatment course varied from 5 days to 4 weeks. The diameter of acupuncture needles used varied between 0.3 mm and 1 mm. Of the eight studies specifying needle length, the shortest was 20 mm, and the longest was 40 mm. A total of eight evaluation indices were employed, with total efficacy rate (TER) and visual analogue scale (VAS) being the most frequently used. Statistically, all intervention groups showed more significant results compared to the control groups. Adverse events were reported in only two studies within the intervention group. Overall, the risk of bias assessment for the selected RCTs ranged from 'some concerns' to 'high risk of bias.' Conclusions : This study showed that acupotomy treatments for migraine were effective.

• The Korean Journal of Pain
• /
• 제13권2호
• /
• pp.143-148
• /
• 2000

Background: Trigeminovascular system is implicated in the pathophysiology of the headache in migraine. This study was designed to evaluate the pattern of Fos protein expression in trigeminal nociceptive central pathway after meningeal stimulation of rats by capsaicin. Methods: The expression of Fos protein was examined by immunohistochemistry in thalamus, brainstem and upper cervical cord (at three levels corresponding to obex, 0.8 mm and 2 mm below obex) 2 hours after intracisternal injection of either diluted capsaicin solution (0.1 ml, $61{\mu}g/ml$) or normal saline (0.1 ml) through a catheter placed in the cisterna magna, or following epidural instillation of diluted capsaicin solution in urethane-anesthetized Sprague-Dawley rats. Results: Fos immunoreactivity was strongly expressed within lamina I, II of bilateral trigeminal nucleus caudalis (TNC) after cisternal capsaicin injection and magnitude of expression was greatest at level 2.0 mm below obex. Epidural capsaicin caused much less labelling than cisternal capsaicin. Fos positive cells were also observed in area postrema, nucleus of the solitary tract, medullary reticular nucleus and midline nuclear groups of the thalamus with similar intensity between capsaicin and control group. Conclusions: These results indicate that the injection of capsaicin into the cisterna magna is an effective stimulus for the induction of Fos protein within TNC through activation of trigeminovascular afferents and this animal model can be useful for the evaluation of the pathophysiology and drug development in migraine and related headache.

• 대한후두음성언어의학회지
• /
• 제13권2호
• /
• pp.164-172
• /
• 2002

The role of botulinum toxin as a therapeutic agent is expanding rapidly in otolaryngology. Botulinum toxin is a protease that blocks the release of acetylcholine from nerve terminals. Its effects are transient and nondestructive, and largely limited to the area in which it is administered These effects are also graded according to the dose, allowing for individualized treatment of patients and disorders. Botulinum toxin has been used primarily to treat disorders of excessive or inappropriate muscle contraction. In the field of otolaryngology, these include spasmodic dysphonia, oromandibular dystonia, and blepharospasm, vocal tics and stuttering, cricopharyngeal achalasia, various tremors and tics, hemifacial spasm, temporomandibular joint disorders and a number of cosmetic applications. Botulinum toxin treatment has recently begun to show some benefit in the control of pain from migraine and tension headache. It may also prove useful in the control of autonomic dysfunction, as in Frey syndrome, sialorrhea, and rhinorrhea. In over 20 yews of use in humans, botulinum toxin has accumulated a considerable safety record, and in many cases represents relief for thousands of patients unaided by other therapy.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제25권2호
• /
• pp.121-128
• /
• 2022

Purpose: Abdominal migraine (AM) is a very common functional gastrointestinal disorder in children. This study reports the clinical features and response of AM to prophylactic treatment in children. Methods: This retrospective study was conducted between January 2010 and December 2019 at the Royal Hospital in the Sultanate of Oman. This study included children aged ≤ 13 years with a diagnosis of AM based on the Rome IV criteria for functional diagnoses. Clinical, demographic, and treatment data were collected. Results: Seventy-four children were identified, of which 43 were eligible for inclusion in this study. The median age at the onset of symptoms was 7 years (range, 2-12 years). The most frequent symptoms were headache (81.4%), nausea (79.1%), and vomiting (72.1%). Of the total cohort, 46.5%, 23.3%, and 6.9% received riboflavin, pizotifen, and propranolol monotherapy, respectively. Combination therapy was also used; 16.3% of children received pizotifen and propranolol, 4.7% received riboflavin and pizotifen, and 2.3% received riboflavin and propranolol. Patients treated with propranolol monotherapy showed 100% clinical improvement and those treated with riboflavin or pizotifen monotherapy showed 90% clinical improvement. Response to combination therapy with pizotifen and propranolol was 71.4%, and with riboflavin and pizotifen was 100%. In addition, treatment response was significantly associated with the presence of vomiting (p=0.039). Conclusion: We found a favorable response to various modalities and combination treatments with riboflavin, pizotifen, and propranolol in children with AM. In addition, the presence of vomiting may predict treatment response.

• Annals of Geriatric Medicine and Research
• /
• 제22권4호
• /
• pp.176-183
• /
• 2018

Background: Although the frequency and intensity of headaches decrease in older adults, headaches in this population are still an important neurological disorder. The purpose of this study was to investigate the associations of headache characteristics in older adults with the development of cardiovascular disease and cognitive dysfunction. Methods: We prospectively enrolled 125 older (${\geq}65$ years old) patients with headache who were making their first visit to outpatient clinics and who had no prior history of cognitive dysfunction from 11 hospitals in Korea between August 2014 and February 2015. We investigated the occurrence of newly developed/or recurrent headache, cardiovascular disease, cognitive dysfunction, and poor functional outcomes. Results: The mean age of all included patients was 72.6 years, 68.8% were women, and 43 (34.4%) had newly developed/or recurrent headache during follow-up. During a median follow-up of 31 months (interquartile range, 28-34 months), 21 participants (16.8%) experienced cardiovascular disease, and 26 (20.8%) developed cognitive dysfunction. Upon multivariate analysis and after adjusting for sex, age, and other factors, presence of newly developed/or recurrent headache was found to be associated with cardiovascular disease (hazard ratio [HR], 4.03; 95% confidence interval [CI], 1.28-12.61; p=0.017) and frequency of headache for the recent 3 months was related with cognitive dysfunction (HR, 1.05; 95% CI, 1.00-1.09; p=0.017) and poor functional outcomes (HR, 1.06; 95% CI, 1.01-1.11; p=0.011). Conclusion: Our study demonstrated that there is an increased risk of cardiovascular disease, cognitive dysfunction, and poor functional outcomes in older patients with frequent, newly developed, or recurrent headache.

• 대한소아신경학회지
• /
• 제26권4호
• /
• pp.263-268
• /
• 2018

목적: 두통과 비만은 모두 소아청소년에서 유병률이 높은 만성 질환이다. 최근 성인뿐만 아니라 소아청소년에서도 두통과 비만의 관련성이 연구되고 있다. 본 연구의 목적은 우리나라 소아청소년 두통 환자에서 비만 유병률을 제시하고 두통 환자의 연령과 성별 및 두통의 형태, 빈도, 강도, 장애 정도에 따른 비만 유병률의 차이를 알아보고자 하였다. 방법: 2015년 1월부터 2018년 3월까지 가톨릭대학교 부천성모병원 소아청소년과 두통 클리닉을 방문한 6세 이상, 18세 이하의 일차두통환자 340명의 의무기록을 후향적으로 조사하였다. 처음 두통클리닉 내원 시 측정한 키와 체중으로 체질량지수를 계산하여 2017년 대한민국 소아청소년 표준성장도표를 이용하여 체질량지수 백분위수를 구하여 비만도를 평가하였으며, 나이, 성별, 키와 체중, 두통의 형태, 빈도, 강도 및 장애 정도에 대한 정보를 수집하였다. 결과: 대상 환자 중 17.6%가 비만이었고 여아에 비하여 남아의 비만 유병률이 높았고 소아 연령과 청소년 연령의 비만 유병률은 차이가 없었다. 두통의 형태, 빈도, 강도, 장애 정도에 따른 비만 유병률의 차이는 없었다. 결론: 본 연구에서 소아청소년 두통 환자의 비만 유병률은 17.6%로 일반 인구(KNHANES, 2013)의 소아청소년 비만 유병률 10%와 비교하여 높았다. 남아의 비만 유병률이 높은 것은 일반 인구와 같았으나 소아 연령의 비만 유병률이 청소년 연령의 비만 유병률이 유사한 것은 일반 인구와는 다른 결과였다. 소아청소년에서 두통과 비만의 관련성에 대한 추가적인 연구가 필요할 것이다.